Skip to content
Home/Companies/Healthcare/Ipsophène
Ipsophène

Ipsophène

Healthcare·France·Active·7yr hold
Entry
2019
Hold
7yr
Status
Active

Who owns Ipsophène?

Ipsophène is currently owned by Grand Sud-Ouest Capital through GSO Innovation (2018 vintage), since 2019.

Hand-verified · updated 2026-04-21

Grand Sud-Ouest Capital
Investor
Grand Sud-Ouest Capital
GSO Innovation · 2018 · Growth

Key facts

HQFrance
SectorHealthcare
Websiteipsophene.eu

More from GSO Innovation

Other portfolio companies in the same fund.

Genoskin
Genoskin
Active
BiotechFrance· 2025
Self & Innov
Self & Innov
Active
FintechFrance· 2024
Ixcys
Ixcys
Active
SoftwareFrance· 2023
Febus Optics
Febus Optics
Active
TMTFrance· 2022
Poool
Poool
Exited 2026
SoftwareFrance· 2022
to
Valoregen
Valoregen
Active
IndustrialsFrance· 2022

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track Ipsophène

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Ipsophène?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Ipsophène.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue